Document:

EXECUTIVE
EMPLOYMENT AGREEMENT

 

EXECUTIVE
EMPLOYMENT AGREEMENT (this "Agreement")
, dated
below and effective as of the 1st day
of April, 2018 ("Effective Date"),
by and between Alterola Biotech Inc a Corporation
organized and existing under the laws of Nevada , (the
"Company") and
Rene Lauritsen (hereinafter
referred to as "Executive"), whose address is
Fyrremejseve 8250 Egga Denmark ,Company
and Executive may be referred to collectively as "Parties"
and individually as "Party".

 

W
I T N E S S E T H:

 

WHEREAS,
the Company desires to employ Executive as Chief Operating Officer and member of the Board of Directors upon the terms
and conditions set forth below and Executive desires to accept employment upon such terms and conditions; and

 

WHEREAS,
the Company and Executive desire to set forth in writing the terms and conditions of th ir agreements and understandings
with respect to Executive's employment by the Company.

 

NOW,
THEREFORE, in consideration of the promises and the mutual covenants and agreements contained
herein and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Parties hereto, intending
to be legally bound, hereby agree as follows:

 

1.                 
EMPLOYMENT. The
Company hereby employs Executive and Executive hereby accepts employment by the Company, upon all the terms and conditions set
forth in this Agreement for the positions of Chief Executive Officer and member of the Company's Board of Directors.

 

2.                 
TERM. Subject
to the provisions for earlier termination set forth in Section 9 hereof, this Agreement shall commence on the Effective Date
hereof and shall continue until the close of business
on the day immediately preceding the 3rd (3rd) anniversary of the Effective Date hereof (the
"Initial Term"). Thereafter,
the Company shall have the right to renew this Agreement for successive two
year periods (each
a "Two
Year Renewal Period"). The
Company shall, if the Company desires not
to renew this Agreement for any Two-Year Renewal Period, give Executive written
notice to that effect at least ninety (90)
days prior to the end of the Initial Term or the Two
Year Renewal Period then in effect (as
the case may be). The period during which this Agreement shall be in
effect as provided herein is referred to herein as the
"Employment Term".

 

3.                 
EXECUTIVE'S REPRESENTATIONS AND WARRANTIES.
Executive represents and warrants
to the Company that he is free to accept employment
with the Company as contemplated herein and has no medical reasons, other written or oral obligations or commitments of any kind
or nature which would in any way interfere with his acceptance of employment pursuant to the terms hereof or the full performance
of his obligations hereunder or the exercise of his best efforts in his employment hereunder or which would otherwise pose any
conflict of interest.

 

    	 		 

    	 

    

 

4.                 
DUTIES AND EXTENT OF SERVICES. 

 

A
Duties and Extent of Service.
During the Employment Term, Executive shall serve as the
Chief Operating Officer ("COO") and member of the Company's
Board of Directors ("Board"), subject
to the terms and conditions of this Agreement. The Executive shall report to and be directly responsible to the Board. The Executive
shall perform, observe and conform to such duties and instructions as from time to time are reasonably assigned or communicated
to him by the Board and which are reasonably consistent with the
employment and status of the Executive as the COO of the Company, and shall make such reports to the Board as may be necessary
to fully and properly inform it of the matters of business of the Company for which the Executive is responsible as well as such
additional reports as the Board may from time to time reasonably request.

 

Executive
agrees to devote sufficient time, skill, attention and energy diligently and competently to perform the duties and responsibilities
assigned to him hereunder or pursuant hereto.
Executive shall be loyal and faithful at all times and constantly endeavor to improve his
ability and his knowledge of the business of the Company in an effort to increase the value of his services for the mutual benefit
of the Company and Executive.

 

Notwithstanding
the above, the Executive may: (i) serve, with or without compensation, on the boards of such companies or corporations, or on
such industry associations or on such government or other public boards or committees (domestic or international) as the Executive
may determine, subject to the prior written approval of the Board, such approval not to be unreasonably withheld, provided that
the objectives of such boards or committees are not, in the opinion of the Board, similar to the interests of the Company and
may devote such reasonable amount of his time (including time
during business hours) to the affairs of such boards or committees as the Executive,
in consultation with the Board, may determine. (ii) managing his and his family's personal
investments, so long as such activities do not materially interfere with the performance of his duties hereunder or create a potential
business conflict or appearance thereof; and (iii) for
insurance and other reasonable purposes, continue to maintain his position as Chairman of the board of Hill International Inc,
provided that this does not create any conflict of interest, or prevent the Executive from performing the duties described above
Board.

 

C.          
Rules and Regulations. Executive agrees to abide by the lawful rules and regulations
of the Company promulgated by the Company from time to time with respect and applicable to the Company's employees generally,
which are all hereby incorporated by reference and made a part of this Agreement.

 

D.        
Location.
Executive will operate from his home office ,
or as deemed beneficial for the Company, the Company and Executive may
mutually agree to a relocation of the office space.

 

5.                 
COMPENSATION. Subject
to the provisions of Section 9 of this Agreement, during the Employment Term for all services rendered under this Agreement, the
Executive shall receive a base Salary according to the provisions of this Section 5. Pursuant to the mutual agreement of the Parties,
Executive's compensation shall be as follows:

 

    	 	2	 

    	 

    

 

$90,000
(Ninety Thousand Dollars) per year payable in cash on a monthly basis of Seven Thousand Five Hundred Per Month paid by electronic
transfer into a designated bank account of Executive on the 1st business day of each month commencing 1ST
May, 2018 with the first quarter being paid in advance .

 

$90,000
( Ninety Thousand Dollars) per year in common shares of the company issued at the 30 day average trading price calculated as of
December 31st each year and paid on January 15th each year commencing January 2019.

 

A
Executive's Salary will be reviewed annually by the Board of Directors,
and at the discretion of the Board, the Executive's Salary may be increased, but not decreased.
The Executive shall not be a member of the Compensation Committee of the Board of Directors. Salary shall be payable monthly in
advance and shall be subject to payroll deductions and tax withholdings in accordance with the Company's usual practices and as
required by law.

 

B.                
The Company shall pay Executive's Salary each month in advance via electronic transfer
of funds to a bank of the Executive' s choice .
Executive will provide Company with all the information required to initiate electronic deposit
of his Salary.

 

C.            
Signing Bonus. Executive
shall be entitled to and is granted Shares of One million (1,000,000)
common shares of Company stock. In the event of a Change of Control (as defined in Section 11 of this Agreement) all unvested
Founder Shares shall immediately vest contemporaneous with the Change of Control or Termination under such provisions. In
the event of Termination (as described in Section 9.E. of this Agreement),
all of the Founder Shares shall fully vest and all restrictions thereon shall lapse to the benefit of the Executive

 

F.        
Annual Bonus. Executive shall be granted bonuses of One Hundred twenty Thousand
Dollars in Company Common stock and a further one per cent (1%) of the Company's annual net income before tax,
to be defined as total Company revenues less operating expenses,
administrative expenses and production related severance and ad valorem taxes, but will exclude
local, state and federal income taxes, depreciation, depletion, amortization, and other non-cash items on an annual basis. The
1% bonus will apply to net income earned on an annual basis by the Company while Executive
is employed by the Company as CFO. Said bonus is not cumulative but based on each year' s
before tax net income. If before tax net income exceeds
$60,000,000 US in any one year then an additional bonus of one per cent (1%) for the amount of net income shall be due Executive.
Any bonus amounts earned shall be paid as a lump sum in cash prior to the end of the first
quarter of the following calendar year.

 

G.               
Incentive Compensation. The Board shall institute an incentive compensation
policy and the Executive shall be entitled to participate in any incentive programs established by the Board,
including, without
limiting the generality of the foregoing, share option plans, share purchase plans, share and/or cash bonus plans and/or financial
assistance plans, in accordance with and on terms and conditions determined by the applicable provisions of such plans as established
by the Company from time to time or by the Board in its sole discretion. The Executive acknowledges that his participation in
these plans or programs will be to such extent and in such amounts as the Board in its sole discretion may decide from time to
time, except for the Options that the Company has agreed to allocate to him as the COO. The Company expects to allocate

 

    	 	3	 

    	 

    

 

about
10% of the Company's management share option pool, typically 10% of shares outstanding, to the management team to be allocated
by the COO based on performance criteria/goals set by the Board,
pursuant to the provisions of this Agreement and Company'
s Share Option Plan, once
it is in existence.

 

I.
Change of Control. In the event of Change of Control (as defined in Section 11 of this Agreement) or Termination (as provided
in Section 9.E. of this Agreement),
such awards shall fully vest and all restrictions thereon shall lapse to the benefit of Executive.

 

		6.	FRINGE
                                         BENEFITS AND EXPENSES.

 

A
Executive Benefits.
Executive shall be entitled to future benefits or fringe benefits made available by the Company
from time to time to all of its other executives generally,
including health and medical insurance paid by the Company but only if
approved by the Board after sufficient funds are available or cash flow from the operation of the Company.
With respect to Health Insurance, Executive
may elect for the Company to reimburse Executive each month for the amount equivalent to what the Company would have paid if
Executive were enrolled in Company'
s medical insurance policy as long as Executive'
s private medical coverage is approved by the Board of Directors as sufficient and proper
to maintain his coverage.

 

C.                
Expenses.
The Company shall reimburse Executive for his normal and reasonable out-of-pocket
costs and expenses in connection with the performance of his duties and responsibilities
hereunder,
subject to the submission of appropriate vouchers and receipts in accordance
with the Company's
policy from time to time in effect,
including sufficient detail to entitle the Company to an income tax deduction
for such paid items,
if such items are so deductible. Company shall create an Employee Expense
Statement Form that every employee will utilize to regularly report his/her out-of-pocket business expenses,
which will be approved and reimbursed within
five business days of submittal of the Employee Expense Statement. Such expenses shall include,
but not be limited to: business class airfare (first class if no business
class is available), appropriate
hotel accommodation, travel
meals and bona fide business expenses and entertainment as allowed by applicable law.
Should extended stays be required in other Company locations,
the Company shall reimburse Executive for extended temporary living expenses.

From
time-to-time the Executive may request an advance against anticipated expenses for any forthcoming business trip or other
expensable event. The Company shall provide the advance per electronic transfer of funds to a bank of the Executive's
choice.

 

D.                
Company Savings Plan (401K). Executive
shall be included in any 401K savings plan as may be approved by the Board
for executives and/or employees.
It is understood that the Company will evaluate such an option for purposes
of employee retention,
but there is no obligation to provide a Company Savings Plan.

 

E.           
Insurance Plans.
Executive shall be included in various insurance plans,
including but not limited to,
short-term disability,
long-term disability,
life insurance and/or accidental death and dismemberment
insurance as may be approved by the Board for executives
and/or employees.

 

    	 	4	 

    	 

    

 

It
is understood that the Company will evaluate such options for purposes of employee retention, but there is no obligation to provide.

 

G.               
Personal Accident and Travel Insurance .
Company shall provide, at its sole cost or reimburse Executive, for a Personal Accident and
Travel Insurance Policy for the benefit of the Executive and his designated beneficiary subject to the Executive complying with
the terms and conditions of the Policy.

 

H.                
Other Benefit Plans. Executive
shall be entitled to participate in all employee benefit plans of the Company as may be implemented from time-to-time.

 

7.                 
VACATIONS .
Executive shall be entitled to a total of six weeks (30 scheduled work days) of vacation
during each full year of the Employment Term beginning with the Effective Date of this Agreement. The
periods during which Executive will
be able to use vacation time shall be at the mutual agreement of the Company and Executive. Vacation time, by mutual agreement,
may be taken at any time during each year of the Employment Term, but for purposes of Section
9, vacation will be deemed to accrue as 0.115
vacation days per calendar day from the Effective Date or the anniversary of such date as applicable. Payment for or carrying
over of unused vacation time shall be governed by the
Company's vacation policy as in effect from time to time.

 

8.                 
FACILITIES. The Company shall provide and
maintain (or cause to be provided and maintained) such facilities, equipment, supplies and personnel as it deems reasonably necessary
for Executive's performance of his duties and responsibilities under this Agreement. Facilities shall include but not be limited
to office expenses, space, telephone (fixed and mobile phone service), fax at both home (if necessary) and office, and computer
equipment for Executive and professional staff as deemed appropriate by Executive.

 

		9.	TERMINATION
                                         OF EMPLOYMENT.

 

A
Termination Events. Notwithstanding
any provisions of this Agreement to the contrary, this Agreement may be terminated only as follows :
(i) by the Company with or without " Cause"
(as hereinafter defined), effective upon the delivery
of written notice to Executive;
(ii) upon Executive's death; (iii) upon Executive becoming "Disabled" (as hereinafter
defined) and receiving written notice of termination from the Company to that effect; (iv) Executive's voluntary termination of
employment with "Good Reason" (as hereinafter
defined); (v) Executive's voluntary
termination of employment for other than "Good Reason"
(as hereinafter defined);
(vi) the non-renewal of this Agreement by the Company at the end of the Initial Term or any
Two Year Renewal Term; or (vii) the refusal of Executive to accept employment for a Two Year Renewal Term after the Company has
elected or is deemed to have elected to have renewed this Agreement.

 

B.                
Definition of Cause and Disabled. For purposes of this Agreement, "Cause"
shall mean and include: (i) a willful or
reckless failure to perform his duties as set forth in Section 4 herein, (ii)
a willful commission of an illegal act for which the Company is directly and adversely affected, (iii) any act of dishonesty
by the Executive bearing directly upon the Company, (iv) a conviction of the Executive for a felony or any other crime involving
moral turpitude and (v) Executive's willful and repeated
failure to fully perform his or her duties and responsibilities as directed by the Board in its reasonable discretion; provided,
however, that Executive shall be

 

    	 	5	 

    	 

    

 

entitled
to receive written notice from the Company setting forth in reasonable detail his or her willful and repeated failure to perform
such duties and shall have the right until 30 days after the date of such notice is received to cure any such act of willful misconduct
or gross negligence.

 

Executive
shall be deemed "Disabled" if Executive is unable,
due to mental, emotional or physical injury or illness, to perform substantially the essential functions of his position, with
or without a reasonable accommodation, for a period of 60 consecutive scheduled work days or a total of 90 scheduled work days
within any period of 365 days. The initial determination as to whether Executive is Disabled shall be made by the physician regularly
treating the condition causing the disability or incapacity. The
Company shall have the right at its sole cost and expense to require Executive to be examined by another physician qualified to
diagnose and treat Executive ' s Disability who is duly
licensed to practice medicine in the jurisdiction of Executive's residence to determine such qualified physician's opinion as
to Executive's Disability. If such qualified
physician's opinion differs from that of the physician treating Executive, both of such physicians shall forthwith jointly select
a third qualified physician so licensed whose opinion, after examination and review of available information, shall be conclusive
and binding upon all Parties hereto. Term,inatio
n of this Agreement for Disability will be effective on the date the Company gives notice
of termination by reason of Disability to Executive.

 

C.                
Effect of Termination for Cause or Executive's Voluntary Termination of Employment
for Other than Good Reason. In the event that this Agreement is terminated by the Company for Cause, or in the event that
Executive voluntarily terminates his employment, including a refusal to accept employment for a Two Year Renewal Period after
the Company has elected or is deemed to have elected to renew this Agreement (other than a voluntary termination for Good Reason),
the Company shall pay to Executive, within thirty (30) days following the date of such termination,
Salary accrued and unpaid through the date of such termination and any accrued and unpaid vacation pay (less vacation already
taken) to which Executive may then be entitled through such date, as provided in Section 7 hereof. All Founder's stocks and stock
options that have vested at that point in time will be granted to the Executive, and he will have a period of up to one year to
exercise his options. Except for the relocation benefits to return to his home base as described in Section 6.B.
hereof, Executive shall not be entitled to any other compensation, remuneration or other sums provided for in this Agreement or
to which Executive might otherwise be entitled hereunder or at law or in equity. In
the event that Executive desires to voluntarily terminate his employment, Executive shall provide the Company with written notice
to such effect three (3) months prior to the date of such voluntary termination. Neither termination of Executive's employment
for Cause nor Executive's voluntary termination without Good Reason shall abrogate Executive's rights or Company's obligations
related to vested stock options accrued through Executive's termination date.

 

D.               
Compensation Upon Death or Disability. Upon
the death of Executive, the Company shall pay to his legal guardian or the legal representative of Executive's estate (or heir
as designated by the legal representative of Executive's estate at such time) within thirty (30) days following the date of Executive's
death, Salary and vacation pay accrued and unpaid through the date of death, and the bonus, if any, earned through the date of
death. All Founder's stocks and stock options that have vested at that point in time will be granted to the Executive's Estate
and the Estate will have a period of up to one year to exercise his options.

 

    	 	6	 

    	 

    

 

-
In the event that Executive is terminated because he is Disabled, the Company shall continue
to pay Salary to Executive until the longer of (i) six (6) months after the date of termination, or (ii) the date that Executive
begins to receive benefits under any long-term disability insurance policy sponsored by the Company for the benefit of Executive.
The Company shall also pay to Executive the bonus, if any, and any accrued and unpaid vacation pay earned through the date of
termination (as described in Section 7). All Founder's
stocks and stock options that have vested at that point
in time will be granted to the Executive, and he will have a period of up to one year to
exercise his options. Relocation benefits to return to his home base as described in Section

6.B.
hereof will remain in effect,

 

E.                 
Compensation Upon Termination Without Cause or Voluntary Termination
for Good Reason.
In the event that the Company terminates this Agreement without Cause or
if Executive terminates this Agreement for Good Reason, Executive shall be entitled to a severance allowance the greater of the
amount of one hundred per cent (100%) of his then annual Salary compensation as set forth in this Agreement, or the total outstanding
Salary for the remaining term of this Agreement thereafter. Per Section 5.H.
of this Agreement, Founders' stock and stock options not yet
vested shall fully vest and all restrictions thereon shall lapse to the
benefit of Executive. Salary and bonus equivalents being paid in a lump-sum within thirty (30)
days following the Executive's termination and the remaining benefits being
provided in the ordinary course as would otherwise have occurred had Executive's employment not terminated.

 

Executive
shall be entitled to terminate this Agreement for "Good Reason".
For purposes of this Agreement, "Good Reason"
means (i) a material breach by Company of this Agreement,

(ii)  
a significant reduction in the nature or scope of Executive's
duties and responsibilities, (iii) the assignment to Executive of duties and responsibilities that are materially inconsistent
with his position, (iv) a
requirement by the Company's Board that Executive take any action or inaction which would violate
applicable law, (v) any requirement that Executive relocate
to an unacceptable working site or (vi) Executive
is not offered a position with comparable duties, pay and benefits following a Change of Control as defined in Section 11 of this
Agreement. Prior to Executive's termination for Good Reason, Executive must give written notice to Company of the reason for his
termination and the reason must remain uncorrected for 30 days following such written notice.
Relocation benefits to return to his home base as described
in Section 6.B. above will remain in effect.

 

F.                 
Key-Man Insurance. The Company shall have the right to obtain a
life insurance policy or policies on the life of Executive, in amounts determined by the Board of Directors of the Company and
Executive agrees to make himself available for such physical examinations and will execute such applications and other documents
and otherwise cooperate with the Company as may be necessary to facilitate the issuance of such policy or policies. In the event
that the Company does obtain a Key-Man Insurance policy (the "Policy") on the life of Executive, all proceeds
payable in respect thereof shall be the property solely of the Company. In the event that Executive's employment terminates for
any reason other than Executive's death, Executive may request that the Policy be assigned to Executive by giving written notice
to the Company to that effect. Subject to obtaining any requisite consent from the insurer, the Company shall, if Executive has
so requested, assign the Policy to Executive subject to Executive's reimbursement to the Company of any premiums paid by the Company
which relate to any period following the date of termination of Executive's employment, and the cash value, if any, of the Policy.

 

    	 	7	 

    	 

    

 

G.               
Resignation.
In the event of
the termination of Executive's services hereunder for any reason (other than by death), Executive agrees that he shall deliver
his written resignation as an officer and/or director of the Company (and its affiliates,
including the Company) to the Board of Directors of the Company,
such resignation to become effective immediately.

 

		10.	CONFIDENTIALITY:
                                         ASSIGNMENT OF INVENTIONS.

 

A
Executive agrees that in performing his normal duties with the Company and by virtue of the relationship of trust and confidence
between the Executive and the Company, he possesses and will possess certain knowledge of operations and other confidential information
of the Company which are of a special and unique nature and value to the Company.
The Executive agrees that during engagement under this Agreement and for one (1) year after
termination of such engagement, the Executive will not, without express written consent of the Company, divulge or use Confidential
business information or trade secrets obtained by the Executive in the course of engagement with the Company, directly or indirectly,
for the Executive' s own benefit or for the benefit of
any other person, firm, business, corporation,
or entity,
except in accordance with this Agreement or with the written permission of the Company.

Executive
may retain one file copy of any and all Confidential business information he has received for his records in accordance with normal
and customary business practices.

 

B.
The Executive agrees that all inventions, innovations
or improvements in the Company's products or methods of conducting its business (including new contributions,
improvements, ideas and discoveries, whether patentable or not) conceived or made by him
during the employment period,
belong to the Company.
The Executive agrees to promptly disclose such inventions, innovations or improvements to
the Company and take all actions reasonably requested by the Company to establish and confirm such ownership

 

11.
CHANGE OF CONTROL. For
the purposes of this agreement, "Change of Control" shall
mean the first to occur of any of the following events while the Executive is employed by the Company:

 

		(i)	any
                                         merger, consolidation,
                                         or reorganization in which Company is not the surviving entity (or
                                         survives only as a subsidiary of an entity),
                                         ·

 

		(ii)	after
                                         one year's operation, any sale, lease,
                                         exchange, or other transfer of
                                         (or agreement to sell,
                                         lease, exchange, or otherwise
                                         transfer) all or substantially all of the assets of Company to any other person or entity
                                         (in one transaction or a series of related transactions),

 

		(iii)	dissolution
                                         or liquidation of Company,

 

(iv)  
a new individual or party,
or group of individuals or parties acting jointly or in concert coming
to own of record or beneficially, or coming to control or exercise direction over,
for the first time, 50% or more of the then issued and outstanding voting
shares of Company,
or

 

    	 	8	 

    	 

    

 

			(v)
                                         as a result of or in connection with a contested election of directors, the persons who
                                         were directors of Company before such election cease to constitute a majority of the
                                         Board; provided,
                                         however,
                                         that the term Change of Control shall not include
                                         any reorganization, merger,
                                         consolidation, sale, lease,
                                         exchange, or
                                         similar transaction involving solely Company
                                         and one or more previously wholly-owned subsidiaries of Company.

 

A
 In the event
of a Change of Control of Company during the term of this Agreement the Executive
may treat this Agreement as terminated by Company without cause as described in Section 9.E. hereof in which event Company shall
be obligated to provide the Executive with the compensation as described in Section 9.E. in lieu of notice. Such payment shall
be payable within thirty (30) days following date on which Company shall notify the Executive of his termination

 

B.
In addition to the provisions of Section 9.E. of this Agreement,
in the event of Change of Control, Executive shall be entitled to a severance allowance the
greater of the amount of one hundred per cent (100%) of
his then annual Salary compensation as set forth in this Agreement, or
the total outstanding Salary for the remaining Employment Term of this Agreement thereafter.
Per ection 9.E.
of this Agreement, stock
options not yet vested shall fully vest and all restrictions thereon shall lapse to the benefit of Executive.
Salary and bonus equivalents being paid in a lump-sum within thirty (30) days following the
Executive' s termination and the remaining benefits being
provided in the ordinary course as would otherwise have occurred had Executive's employment not terminated.
Such awards shall fully vest and all restrictions thereon shall lapse to the benefit of Executive.

 

Subject
to all applicable regulations governing Company' s common
shares, if any person, or any persons and any associate
of such person begins a tender or exchange offer, circulates a proxy
to shareholders or takes other steps to effect a takeover of the control of Company (a "Take
Over") all incentive stock option to purchase common
shares of the Company owned by Company shall vest immediately
on the commencement of such Take Over.

 

For
purposes of this Agreement takeover of control shall be evidenced by the acquisition any person,
or by any person and its associates, and
whether directly or indirectly, of common shares of the Company that, when
added to all other common shares of Company at the time held by such person and its affiliates,
totals for the first time more than 50% of the outstanding common shares of Company.

 

		12.	INDEMNIFICATION
                                         AS OFFICER

 

The
Company hereby agrees to indemnify the Executive and hold him
harmless, and to defend to the fullest extent permitted by applicable law against and in respect to any and all actions,
suits,
proceedings, claims,
demands,
judgments, costs,
expenses (including reasonable attorney' s
fees), losses and damages resulting from the Executive'
s good faith performance of his duties and obligations with the Company.

 

13.              
LIABILITY INSURANCE. The Company agrees that the
Executive will have no personal liability resulting from the Executive'
s good faith performance of his duties and obligations with the Company,
at any time during the Term of this Agreement, and
while potential liability exists after the term of this Agreement. As of the Effective Date of this Agreement the Company shall
purchase, maintain, and cover the Executive under directors
and officer's liability

 

    	 	9	 

    	 

    

("D&O")
insurance in amounts acceptable to the Executive, normal to the business of the Company both during the Employment Term and while
potential liability exists after the Employment Term of this Agreement in the same amount and the same extent as the Company covers
all its other officers and directors.

 

14.              
APPLICABLE LAW.
This Agreement shall be governed by and construed
pursuant to the laws of the State of Nevada, without giving effect to conflicts of laws principles.

 

15.              
FOREIGN CORRUPT PRACTICES ACTIn
the event the Company elects to do business outside of the United States, the Executive agrees and covenants that he has not,
and will not make, in the performance of this Agreement,
any payment, loan or gift or promise or offer of payment, loan or gift of any money or anything of value, directly or indirectly:

 

(i)   
to or for the use or benefit of any official employee of any government or agency or instrumentality
of any such government;

 

		(ii)	to
                                         any political party or official or candidate thereof;

 

		(iii)	to
                                         any other person if Company
                                         or Executive knows or has reason to know that any part of such payment, loan or gift
                                         will be directly or indirectly given or paid to any such governmental official or employee
                                         or political party or candidate or official thereof; or

 

		(iv)	to
                                         any other person or any entity, the payment of which would violate either the laws or
                                         policies of the United States, or any country where the Company is seeking to or doing
                                         business .

 

Company
will make its counsel available to Executive to advise on the laws of the respective countries relating to this subject.

 

Company
also agrees and covenants that it will not require Executive to engage in, on behalf of Company, any of the aforementioned activities
or practices.

 

16.              
FORCE MAJEURE. The obligations
of each Party under this Agreement, other than the obligations to make payments of money including but not limited to Compensation
as described in Section 5, and fringe benefits and expenses as described in Section 6 of this Agreement, and provide other benefits
and perquisites (including but not limited to the vesting of stock options or stock awards) to Executive as provided in this Agreement,
shall be excused or suspended while such Party is prevented or hindered from complying therewith, in whole or in part, by Force
Majeure (being an unavoidable and unforeseeable event outside of the reasonable control of the Parties hereto and not inclusive
of the death or incapacity of the Executive).
In the event Force Majeure causes a suspension of the
obligations of any Party as aforesaid, such Party shall give notice thereof as soon as reasonably possible to the other Party
stating the date and extent of such suspension, whether in whole or in part, and the nature of the Force Majeure. Any Party whose
obligations have been suspended as aforesaid shall take all reasonable steps to remove the Force Majeure situation and shall resume
the performances of such obligations as soon as reasonably possible after the removal of the Force Majeure and shall so notify
the other Party

    	 	10	 

    	 

    

 

  
17.
NOTICES.
Any notices required or permitted to be given pursuant
to this Agreement shall be sufficient, if in writing and sent by certified or registered mail, return receipt requested,
to his residence,
in the case of Executive,
and in the case of the Company to address set forth
on the first page hereof.

 

18.             
ASSIGNMENT. This Agreement
shall inure to the benefit of and be binding upon the Parties hereto and their respective legal representatives, heirs, assignees
and/or successors in interest of any kind
whatsoever;
provided, however,
that Executive acknowledges and agrees that he cannot
assign or delegate any of his rights, duties,
responsibilities or obligations hereunder to any
other person or entity except as required for good governance
during periods of vacation or other leaves of absence as agreed by the Board. In such cases,
a Power-of-Attorney shall be issued making such authorization.
The Company may assign its rights under this Agreement to any affiliate of the Company or to any entity upon any sale of all or
substantially all of the Company's assets,
or upon any merger or consolidation of the Company with
or into any other entity.
Such assignment
may constitute a Change of Control as defined in Section 11 of this Agreement.

 

19.             
SEVERABILITY. If any provision
of this Agreement shall be held to be invalid or unenforceable, and is not reformed by a court of competent jurisdiction, such
invalidity or unenforceability shall attach only to such provision and shall not in any way affect or render invalid or unenforceable
any other provision of this Agreement, and
this Agreement shall be carried out as if such invalid or unenforceable provision were not contained herein.

 

20.             
NO WAIVER. A waiver of any
breach or violation of any term,
provision or covenant contained herein shall not be
deemed a continuing waiver or a waiver of any future or past breach or violation.
No oral waiver shall be binding.

 

21.             
ARBITRATION . Except
as provided in Section 14 hereof,
any dispute, claim arising
out of any matter involving this Agreement shall be submitted to binding and non appealable arbitration in accordance with the
rules of the American Arbitration Association. Any
such arbitration
shall be held New York. The arbitrator so selected must
enforce the terms of this Agreement and must rule in accordance with New York law.
Judgment upon any award rendered by
the arbitrators may be entered in any court having

jurisdiction.
The prevailing Party in any such arbitration will be entitled to an award of its reasonable attorneys' fees and expenses in connection
with such arbitration and enforcement of any award or
relief granted therein.

 

22.             
COUNTERPARTS. This Agreement
may be executed in counterparts, each of which shall be an original,
but all of which together shall constitute one and the
same instrument and it shall not be necessary in making proof of this agreement to account for all such counterparts.

 

23.             
MISCELLANEOUS. No provision
of this Agreement may be modified, waived
or discharged unless such waiver,
modification or discharge is agreed in writing and signed
by the Executive
and such officer or director as may be designated by
the Board.

 

IN
WITNESS WHEREOF, the
undersigned have hereunto set their hands to this Agreement on the day and year first above written.

 

    	 	11	 

    	 

    

 

COMPANY

 

By:
/s/ Peter Maddocks

 

Name:
Peter Maddocks

 

Title:President

 

Dated:
______________________________

 

EXECUTIVE

 

By
: /s/ Rene Lauritsen

 

Name:
Rene Lauritsen

 

Title:
Chief Operating Officer

Dated:
 April 1st 2018

 

    	 	12Exhibit 4.1

       

      WARRANT AGREEMENT

       

      THIS WARRANT AGREEMENT (this “Agreement”), dated as of December 22, 2020, is by and between CF Acquisition Corp. IV, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”, also referred to herein, in its capacity as the Company’s transfer agent, as the “Transfer Agent”).

       

      WHEREAS, on December 22, 2020, the Company entered into that certain Private Placement Units Purchase Agreement with CFAC Holdings IV, LLC, a Delaware limited liability company (the “Sponsor”), pursuant to which the Sponsor agreed to purchase an aggregate of 1,000,000 units, each unit consisting of one share of Common Stock (as defined below) and one-third of one warrant, simultaneously with the
        closing of the Offering (as defined below), such warrants bearing the legend set forth in Exhibit B hereto (the “Private Placement Warrants”), at a purchase price of $10.00 per unit; and

       

      WHEREAS, the Company is engaged in an initial public offering (the “Offering”) of units of the Company’s equity securities, each such unit comprised of one
        share of Common Stock and one-third of one redeemable Public Warrant (as defined below) (the “Units”) and, in connection therewith, has determined to issue and deliver up to 15,000,000
        warrants (or up to 17,250,000 warrants if the underwriter’s over-allotment is exercised in full) to public investors in the Offering (the “Public Warrants”); and

       

      WHEREAS, the Company has entered into that certain Forward Purchase Contract, dated as of December 22, 2020, with the Sponsor, pursuant to which the Sponsor has agreed to purchase 1,500,000 Units, each such Unit
        comprised of one share of Common Stock and one-third of one warrant, such warrants bearing the legend set forth in Exhibit B hereto (the “Forward Purchase Warrants”), and 375,000 shares of
        Common Stock, such purchase to occur simultaneously with the Company’s initial Business Combination (as defined below). Each whole Warrant entitles the holder thereof to purchase one share of Common Stock; and

       

      WHEREAS, the Company has filed with the Securities and Exchange Commission (the “Commission”) a registration statements on Form S-1, File Nos. 333-251184 and
        333-251622 (the “Registration Statement”) and prospectus (the “Prospectus”),

        for the registration, under the Securities Act of 1933, as amended (the “Securities Act”), of the Units and the Public Warrants
        and the Common Stock included in the Units; and

       

      WHEREAS, following consummation of the Offering, the Company may issue additional warrants (“Post-IPO Warrants” and together with the Private Placement
        Warrants, the Forward Purchase Warrants, and the Public Warrants, the “Warrants”) in connection with, or following the consummation by the Company of, a Business Combination; and

       

      WHEREAS, each whole Warrant entitles the holder thereof to purchase one share of Common Stock of the Company, par value $0.0001 per share (“Common Stock”),
        for $11.50 per share, subject to adjustment as described herein; and

       

      WHEREAS, the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer, exchange, redemption and exercise of
        the Warrants; and

       

      WHEREAS, the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of rights, and immunities of the
        Company, the Warrant Agent, and the holders of the Warrants; and

       

      WHEREAS, all acts and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf of the Warrant Agent, as provided herein, the
        valid, binding and legal obligations of the Company, and to authorize the execution and delivery of this Agreement.

       

      NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

       

      1.   Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the
        same in accordance with the terms and conditions set forth in this Agreement.

       

      
        
          

      

      2.   Warrants.

       

      2.1 Form of Warrant. Each Warrant shall be issued in registered form only, and, if a physical certificate is issued, shall be in substantially the form of Exhibit A hereto, the provisions of which
        are incorporated herein and shall be signed by, or bear the facsimile signature of, the Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer, Secretary or other principal officer of the Company. In the event the person
        whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be
        such at the date of issuance.

       

      2.2 Effect of Countersignature. If a physical certificate is issued, unless and until countersigned by the Warrant Agent pursuant to this Agreement, a Warrant certificate shall be invalid and of no effect
        and may not be exercised by the holder thereof.

       

      2.3 Registration.

       

      2.3.1 Warrant Register. The Warrant Agent shall maintain books (the “Warrant Register”)
        for the registration of original issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and register the Warrants in the names of the respective holders thereof in such
        denominations and otherwise in accordance with instructions delivered to the Warrant Agent by the Company. All of the Public Warrants shall initially be represented by one or more book-entry certificates (each, a “Book-Entry

          Warrant Certificate”) deposited with The Depository Trust Company (the “Depositary”) and registered in the name of Cede & Co., a nominee of the Depositary. Ownership of
        beneficial interests in the Public Warrants shall be shown on, and the transfer of such ownership shall be effected through, records maintained by (i) the Depositary or its nominee for each Book-Entry Warrant Certificate, or (ii) institutions that
        have accounts with the Depositary (each such institution, with respect to a Warrant in its account, a “Participant”).

       

      If the Depositary subsequently ceases to make its book-entry settlement system available for the Public Warrants, the Company may instruct the Warrant Agent regarding making other arrangements for book-entry
        settlement. In the event that the Public Warrants are not eligible for, or it is no longer necessary to have the Public Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to the Depositary to deliver to the
        Warrant Agent for cancellation each Book-Entry Warrant Certificate, and the Company shall instruct the Warrant Agent to deliver to the Depositary definitive certificates in physical form evidencing such Warrants (“Definitive Warrant Certificate”). Such Definitive Warrant Certificate shall be in the form annexed hereto as Exhibit A, with appropriate insertions, modifications and omissions, as provided above.

       

      2.3.2 Registered Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat the person in whose name such Warrant is registered in the
        Warrant Register (the “Registered Holder”) as the absolute owner of such Warrant and of each Warrant represented thereby
        (notwithstanding any notation of ownership or other writing on a Definitive Warrant Certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes, and neither the
        Company nor the Warrant Agent shall be affected by any notice to the contrary.

       

      2.4 Detachability of Warrants. The Common Stock and Public Warrants comprising the Units shall begin separate trading on the 52nd day following the date of the Prospectus or, if such 52nd day is not on a
        day, other than a Saturday, Sunday or federal holiday, on which banks in New York City are generally open for normal business (a “Business Day”), then on the immediately succeeding Business Day following such date, or earlier (the “Detachment Date”)
        with the consent of Cantor, as representative of the several underwriters, but in no event shall the Common Stock and the Public Warrants comprising the Units be separately traded until (A) the Company has filed a current report on Form 8-K with
        the Commission containing an audited balance sheet reflecting the receipt by the Company of the gross proceeds of the Offering, including the proceeds received by the Company from the exercise by the underwriters of their right to purchase
        additional Units in the Offering (the “Over-allotment Option”), if the Over-allotment Option is exercised prior to the filing of
        the Form 8-K, and (B) the Company issues a press release and files with the Commission a current report on Form 8-K announcing when such separate trading shall begin.

       

      2.5 No Fractional Warrants Other Than as Part of Units. The Company shall not issue fractional Warrants other than as part of units, each of which is comprised of one share of Common Stock and one-third of
        one Warrant. If, upon the detachment of Warrants from Units or otherwise, a holder of Warrants would be entitled to receive a fractional Warrant, the Company shall round down to the nearest whole number the number of Warrants to be issued to such
        holder.

       

      
        
          

      

      2.6 Private Placement Warrants and Forward Purchase Warrants. The Private Placement Warrants and Forward Purchase Warrants shall be identical to the Public Warrants, except that so long as they are held by
        the Sponsor or any Permitted Transferees (as defined below), as applicable, the Private Placement Warrants and Forward Purchase Warrants (i) may be exercised for cash or on a cashless basis, pursuant to subsection 3.3.1(c) hereof, (ii) may
        not be transferred, assigned or sold until thirty (30) days after the completion by the Company of an initial Business Combination, and (iii) shall not be redeemable by the Company; provided, however, that in the case of (ii), the
        Private Placement Warrants and Forward Purchase Warrants and any shares of Common Stock held by the Sponsor or any Permitted Transferees, as applicable, and issued upon exercise of the Private Placement Warrants and Forward Purchase Warrants may be
        transferred by the holders thereof:

       

      (a) to the Company’s officers or directors, any current or future affiliate or family member of any of the Company’s officers or directors, any current or future affiliate of the Sponsor or to any member(s),
        directors, officers or employees of the Sponsor or any of their current or future affiliates;

       

      (b) in the case of an individual, by gift to a member such individual’s immediate family or to a trust, the beneficiary of which is a member of such individual’s immediate family, a current or future affiliate of
        such individual or to a charitable organization;

       

      (c) in the case of an individual, by virtue of the laws of descent and distribution upon death of such person;

       

      (d) in the case of an individual, pursuant to a qualified domestic relations order;

       

      (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of an initial Business Combination at prices no greater than the
        price at which the Warrants were originally purchased;

       

      (f) in the event of the Company’s liquidation prior to consummation of the Company’s Business Combination; or

       

      (g) by virtue of the laws of the state of Delaware or the Sponsor’s limited liability company agreement upon dissolution of the Sponsor; provided, however, that, in the case of clauses (a) through
        (e) or (g), these transferees (the “Permitted Transferees”) enter into a written agreement with the Company agreeing to be bound
        by the transfer restrictions in this Agreement.

       

      2.7 Post-IPO Warrants. The Post-IPO Warrants, when and if issued, shall have the same terms and be in the same form as the Public Warrants except as may be agreed upon by the Company.

       

      3.   Terms and Exercise of Warrants.

       

      3.1 Warrant Price. Each Warrant shall entitle the Registered Holder thereof, subject to the provisions of such Warrant and of this Agreement, to purchase from the Company the number of shares of Common Stock
        stated therein, at the price of $11.50 per share, subject to the adjustments provided in Section 4 hereof and in the last sentence of this Section 3.1. The term “Warrant Price”
        as used in this Agreement shall mean the price per share at which shares of Common Stock may be purchased at the time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration Date
        (as defined below) for a period of not less than twenty (20) Business Days, provided, that the Company shall provide at least twenty (20) days prior written notice of such reduction to Registered Holders of the Warrants and, provided further that
        any such reduction shall be identical among all of the Warrants.

       

      3.2 Duration of Warrants. A Warrant may be exercised only during the period (the “Exercise Period”)

        commencing on the later of: (i) the date that is thirty (30) days after the first date on which the Company completes a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination, involving the
        Company and one or more businesses (a “Business Combination”), and (ii) the date that is twelve (12) months from the date of the
        closing of the Offering, and terminating at 5:00 p.m., New York City time on the earlier to occur of: (x) the date that is five (5) years after the date on which the Company completes its initial Business Combination, (y) the liquidation of the
        Company, or (z) other than with respect to the Private Placement Warrants and Forward Purchase Warrants, the Redemption Date (as defined below) as provided in Section 6.2 hereof (the “Expiration Date”); provided, however, that the exercise of any Warrant shall be subject to the satisfaction of any applicable conditions, as set forth in subsection 3.3.2 below
        with respect to an effective registration statement. Except with respect to the right to receive the Redemption Price (as defined below) (other than with respect to a Private Placement Warrant or a Forward Purchase Warrant) in the event of a
        redemption (as set forth in Section 6 hereof), each outstanding Warrant (other than a Private Placement Warrant or a Forward Purchase Warrant in the event of a redemption) not exercised on or before the Expiration Date shall become void,
        and all rights thereunder and all rights in respect thereof under this Agreement shall cease at 5:00 p.m. New York City time on the Expiration Date. The Company in its sole discretion may extend the duration of the Warrants by delaying the
        Expiration Date; provided, that the Company shall provide at least twenty (20) days prior written notice of any such extension to Registered Holders of the Warrants and, provided further that any such extension shall be identical in
        duration among all the Warrants.

       

      
        
          

      

      3.3 Exercise of Warrants.

       

      3.3.1 Payment. Subject to the provisions of the Warrant and this Agreement, a Warrant may be exercised by the Registered Holder thereof by delivering to the Warrant Agent at its corporate trust department
        (i) the Definitive Warrant Certificate evidencing the Warrants to be exercised, or, in the case of a Book-Entry Warrant Certificate, the Warrants to be exercised (the “Book-Entry Warrants”)

        on the records of the Depositary to an account of the Warrant Agent at the Depositary designated for such purposes in writing by the Warrant Agent to the Depositary from time to time, (ii) an election to purchase (“Election to Purchase”) shares of Common Stock pursuant to the exercise of a Warrant, properly completed and executed by the Registered Holder on the reverse of the Definitive Warrant Certificate or, in the case of a
        Book-Entry Warrant Certificate, properly delivered by the Participant in accordance with the Depositary’s procedures, and (iii) payment in full of the Warrant Price for each full share of Common Stock as to which the Warrant is exercised and any
        and all applicable taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the shares of Common Stock and the issuance of such shares of Common Stock, as follows:

       

      (a) by certified check payable to the order of the Warrant Agent or by wire transfer;

       

      (b) in the event of a redemption pursuant to Section 6 hereof in which the Company’s board of directors (the “Board”) has elected to require all
        holders of the Warrants to exercise such Warrants on a “cashless basis,” by surrendering the Warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock
        underlying the Warrants, multiplied by the difference between the Warrant Price and the “Fair Market Value”, as defined in this subsection 3.3.1(b) by (y) the Fair Market Value. Solely for purposes of this subsection 3.3.1(b) and Section

          6.3, the “Fair Market Value” shall mean the average last reported sale price of the Common Stock for the ten (10) trading days ending on the third trading day prior to the date on
        which the notice of redemption is sent to the holders of the Warrants, pursuant to Section 6 hereof;

       

      (c) with respect to any Private Placement Warrant or Forward Purchase Warrant, so long as such Private Placement Warrant or Forward Purchase Warrant is held by the Sponsor or a Permitted Transferee, as applicable,
        by surrendering the Warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the difference between the Warrant
        Price and the “Fair Market Value”, as defined in this subsection 3.3.1(c), by (y) the Fair Market Value. Solely for purposes of this subsection 3.3.1(c), the “Fair Market Value”
        shall mean the average last reported sale price of the Common Stock for the ten (10) trading days ending on the third trading day prior to the date on which notice of exercise of the Warrant is sent to the Warrant Agent; or

       

      (d) as provided in Section 7.4 hereof.

       

      
        
          

      

      3.3.2 Issuance of Shares of Common Stock on Exercise. As soon as practicable after the exercise of any Warrant and the clearance of the funds in payment of the Warrant Price (if payment is pursuant to subsection

          3.3.1(a)), the Company shall issue to the Registered Holder of such Warrant a book-entry position or certificate, as applicable, for the number of full shares of Common Stock to which he, she or it is entitled, registered in such name or
        names as may be directed by him, her or it, and if such Warrant shall not have been exercised in full, a new book-entry position or countersigned Warrant, as applicable, for the number of shares of Common Stock as to which such Warrant shall not
        have been exercised. If fewer than all the Warrants evidenced by a Book-Entry Warrant Certificate are exercised, a notation shall be made to the records maintained by the Depositary, its nominee for each Book-Entry Warrant Certificate, or a
        Participant, as appropriate, evidencing the balance of the Warrants remaining after such exercise. Notwithstanding the foregoing, the Company shall not be obligated to deliver any shares of Common Stock pursuant to the exercise of a Warrant and
        shall have no obligation to settle such Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Common Stock underlying the Public Warrants is then effective and a prospectus relating thereto is
        current, subject to the Company’s satisfying its obligations under Section 7.4. No Warrant shall be exercisable and the Company shall not be obligated to issue shares of Common Stock upon exercise of a Warrant unless the Common Stock
        issuable upon such Warrant exercise has been registered, qualified or deemed to be exempt from registration or qualification under the securities laws of the state of residence of the Registered Holder of the Warrants. In the event that the
        conditions in the two immediately preceding sentences are not satisfied with respect to a Warrant, the holder of such Warrant shall not be entitled to exercise such Warrant and such Warrant may have no value and expire worthless, in which case the
        purchaser of a Unit containing such Public Warrants shall have paid the full purchase price for the Unit solely for the shares of Common Stock underlying such Unit. In no event will the Company be required to net cash settle the Warrant exercise.
        The Company may require holders of Public Warrants to settle the Warrant on a “cashless basis” pursuant to Section 7.4. If, by reason of any exercise of Warrants on a “cashless basis”, the holder of any Warrant would be entitled, upon the
        exercise of such Warrant, to receive a fractional interest in a share of Common Stock, the Company shall round down to the nearest whole number, the number of shares of Common Stock to be issued to such holder. Notwithstanding anything herein to
        the contrary, for as long as any of the Private Warrants and Forward Purchase Warrants are held by the Sponsor or its designees or affiliates, such Warrants may not be exercised after five years from the effective date of the Registration
        Statement.

       

      3.3.3 Valid Issuance. All shares of Common Stock issued upon the proper exercise of a Warrant in conformity with this Agreement shall be validly issued, fully paid and non-assessable.

       

      3.3.4 Date of Issuance. Each person in whose name any book-entry position or certificate, as applicable, for shares of Common Stock is issued shall for all purposes be deemed to have become the holder of
        record of such shares of Common Stock on the date on which the Warrant, or book-entry position representing such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of delivery of such certificate in the
        case of a certificated Warrant, except that, if the date of such surrender and payment is a date when the share transfer books of the Company or book-entry system of the Warrant Agent are closed, such person shall be deemed to have become the
        holder of such shares of Common Stock at the close of business on the next succeeding date on which the share transfer books or book-entry system are open.

       

      3.3.5 Maximum Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the provisions contained in this subsection 3.3.5; provided, however,
        no holder of a Warrant shall be subject to this subsection 3.3.5 unless he, she or it makes such election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder’s Warrant, and such holder shall
        not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own in excess of 4.9% or 9.8%
        (or such other amount as specified by the holder) (the “Maximum Percentage”) of the shares of Common Stock outstanding
        immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such person and its affiliates shall include the number of shares of Common Stock
        issuable upon exercise of the Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of Common Stock that would be issuable upon (x) exercise of the remaining, unexercised portion of the Warrant
        beneficially owned by such person and its affiliates and (y) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such person and its affiliates (including, without
        limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this
        paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). For purposes of the Warrant, in determining the number of outstanding shares of Common Stock, the holder may rely on the number of outstanding shares of Common Stock as reflected in (1) the Company’s most recent
        annual report on Form 10-K, quarterly report on Form 10-Q, current report on Form 8-K or other public filing with the Commission as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or the
        Transfer Agent setting forth the number of shares of Common Stock outstanding. For any reason at any time, upon the written request of the holder of the Warrant, the Company shall, within two (2) Business Days, confirm orally and in writing to such
        holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of equity securities of the Company by the holder and
        its affiliates since the date as of which such number of outstanding shares of Common Stock was reported. By written notice to the Company, the holder of a Warrant may from time to time increase or decrease the Maximum Percentage applicable to such
        holder to any other percentage specified in such notice; provided, however, that any such increase shall not be effective until the sixty-first (61st) day after such notice is delivered to the Company.

       

      
        
          

      

      4.   Adjustments.

       

      4.1 Stock Dividends.

       

      4.1.1 Split-Ups. If after the date hereof, and subject to the provisions of Section 4.6 below, the number of outstanding shares of Common Stock is increased by a stock dividend payable in shares of
        Common Stock, or by a split-up of shares of Common Stock or other similar event, then, on the effective date of such stock dividend, split-up or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be
        increased in proportion to such increase in the outstanding shares of Common Stock. A rights offering to holders of the Common Stock entitling holders to purchase shares of Common Stock at a price less than the “Fair Market Value” (as defined
        below) shall be deemed a stock dividend of a number of shares of Common Stock equal to the product of (i) the number of shares of Common Stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights
        offering that are convertible into or exercisable for the Common Stock) and (ii) one (1) minus the quotient of (x) the price per share of Common Stock paid in such rights offering divided by (y) the Fair Market Value. For purposes of this subsection

          4.1.1, (i) if the rights offering is for securities convertible into or exercisable for Common Stock, in determining the price payable for Common Stock, there shall be taken into account any consideration received for such rights, as well as
        any additional amount payable upon exercise or conversion and (ii) “Fair Market Value” means the volume weighted last reported average price of the Common Stock as reported during the ten
        (10) trading day period ending on the trading day prior to the first date on which the shares of Common Stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

       

      4.1.2 Extraordinary Dividends. If the Company, at any time while the Warrants are outstanding and unexpired, shall pay a dividend or make a distribution in cash, securities or other assets to the holders of
        the Common Stock on account of such shares of Common Stock (or other shares of the Company’s capital stock into which the Warrants are convertible), other than (a) as described in subsection 4.1.1 above, (b) Ordinary Cash Dividends (as
        defined below), (c) to satisfy the redemption rights of the holders of the Common Stock in connection with a proposed initial Business Combination, (d) to satisfy the redemption rights of the holders of Common Stock in connection with a stockholder
        vote to amend the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to allow redemption in connection with our initial Business Combination or to redeem 100% of the public
        shares of Common Stock if the Company does not complete the Business Combination within the period set forth in the Company’s amended and restated certificate of incorporation or (e) in connection with the redemption of public shares of Common
        Stock upon the failure of the Company to complete its initial Business Combination and any subsequent distribution of its assets upon its liquidation (any such non-excluded event being referred to herein as an “Extraordinary Dividend”), then the Warrant Price shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the
        amount of cash and/or the fair market value (as determined by the Board, in good faith) of any securities or other assets paid on each share of Common Stock in respect of such Extraordinary Dividend. For purposes of this subsection 4.1.2, “Ordinary Cash Dividends” means any cash dividend or cash distribution
        which, when combined on a per share basis, with the per share amounts of all other cash dividends and cash distributions paid on the Common Stock during the 365-day period ending on the date of declaration of such dividend or distribution (as
        adjusted to appropriately reflect any of the events referred to in other subsections of this Section 4 and excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant Price or to the number of shares of
        Common Stock issuable on exercise of each Warrant) does not exceed $0.50 (being 5% of the offering price of the Units in the Offering).

       

      4.2 Aggregation of Shares. If after the date hereof, and subject to the provisions of Section 4.6 hereof, the number of outstanding shares of Common Stock is decreased by a consolidation,
        combination, reverse stock split or reclassification of shares of Common Stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of shares of
        Common Stock issuable on exercise of each Warrant shall be decreased in proportion to such decrease in outstanding shares of Common Stock.

       

      4.3 Adjustments in Exercise Price.

       

      
        
          

      

      4.3.1 Whenever the number of shares of Common Stock purchasable upon the exercise of the Warrants is adjusted, as provided in subsection 4.1.1 or Section 4.2 above, the Warrant Price shall be adjusted
        (to the nearest cent) by multiplying such Warrant Price immediately prior to such adjustment by a fraction (x) the numerator of which shall be the number of shares of Common Stock purchasable upon the exercise of the Warrants immediately prior to
        such adjustment, and (y) the denominator of which shall be the number of shares of Common Stock so purchasable immediately thereafter.

       

      4.3.2 If (i) the Company issues additional shares of Common Stock or securities convertible into or exercisable or exchangeable for shares of Common Stock for capital raising purposes in connection with the closing
        of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock, with such issue price or effective issue price to be determined in good faith by the Board (and in the case of any such
        issuance to the Sponsor or its affiliates, without taking into account any founder shares held by such holder or affiliates, as applicable, prior to such issuance) (the “New Issuance Price”),

        (ii) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation thereof (net of
        redemptions) and (iii) the volume weighted average trading price of the Common Stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the Warrant Price shall be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the New Issuance Price and the
        Redemption Price (as defined below) shall be adjusted to equal to 180% of the greater of the Market Value and the Newly Issued Price.

       

      4.4 Replacement of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding shares of Common Stock (other than a change under subsections 4.1.1 or 4.1.2
        or Section 4.2 hereof or that solely affects the par value of such shares of Common Stock), or in the case of any merger or consolidation of the Company with or into another entity or conversion of the Company as another entity (other than
        a consolidation or merger in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding shares of Common Stock), or in the case of any sale or conveyance to another entity
        of the assets or other property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the holders of the Warrants shall thereafter have the right to purchase and receive, upon the basis and
        upon the terms and conditions specified in the Warrants and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares
        of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the Warrants would have received
        if such holder had exercised his, her or its Warrant(s) immediately prior to such event (the “Alternative Issuance” ); provided, however,
        that in connection with the closing of any such consolidation, merger, sale or conveyance, the successor or purchasing entity shall execute an amendment hereto with the Warrant Agent providing for delivery of such Alternative Issuance; provided,
        further, that (i) if the holders of the Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of
        securities, cash or other assets constituting the Alternative Issuance for which each Warrant shall become exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders of the Common Stock in such
        consolidation or merger that affirmatively make such election, and (ii) if a tender, exchange or redemption offer shall have been made to and accepted by the holders of the Common Stock (other than a tender, exchange or redemption offer made by the
        Company in connection with redemption rights held by stockholders of the Company as provided for in the Company’s amended and restated certificate of incorporation or as a result of the repurchase of shares of Common Stock by the Company if a
        proposed initial Business Combination is presented to the stockholders of the Company for approval) under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the
        meaning of Rule 13d-5(b)(1) under the Exchange Act (or any successor rule)) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act (or any successor rule))
        and any members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act (or any successor rule)) more than 50% of the outstanding shares of Common Stock, the
        holder of a Warrant shall be entitled to receive as the Alternative Issuance, the highest amount of cash, securities or other property to which such holder would actually have been entitled as a stockholder if such Warrant holder had exercised the
        Warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the Common Stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the
        consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in this Section 4; provided, further, that if less than 70% of the consideration receivable by the holders of
        the Common Stock in the applicable event is payable in the form of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for
        trading or quoted immediately following such event, and if the Registered Holder properly exercises the Warrant within thirty (30) days following the public disclosure of the consummation of such applicable event by the Company pursuant to a
        Current Report on Form 8-K filed with the Commission, the Warrant Price shall be reduced by an amount (in dollars) (but in no event less than zero) equal to the difference of (i) the Warrant Price in effect prior to such reduction minus (ii) (A)
        the Per Share Consideration (as defined below) minus (B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a Warrant immediately prior to the consummation of the applicable event based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial
        Markets (“Bloomberg”). For purposes of calculating such amount, (1) Section 6 of this Agreement shall be taken into account, (2) the price of each share of Common Stock shall be
        the volume weighted last reported average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event, (3) the assumed volatility shall be the 90 day
        volatility obtained from the HVT function on Bloomberg determined as of the trading day immediately prior to the day of the announcement of the applicable event, and (4) the assumed risk-free interest rate shall correspond to the U.S. Treasury rate
        for a period equal to the remaining term of the Warrant. “Per Share Consideration”
        means (i) if the consideration paid to holders of the Common Stock consists exclusively of cash, the amount of such cash per share of Common Stock, and (ii) in all other cases, the volume weighted last reported average price of the Common Stock as
        reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event. If any reclassification or reorganization also results in a change in shares of Common Stock covered by subsection
          4.1.1, then such adjustment shall be made pursuant to subsection 4.1.1 or Sections 4.2, 4.3 and this Section 4.4. The provisions of this Section 4.4 shall similarly apply to successive
        reclassifications, reorganizations, mergers or consolidations, sales or other transfers. In no event will the Warrant Price be reduced to less than the par value per share issuable upon exercise of the Warrant.

       

      
        
          

      

      4.5 Notices of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares of Common Stock issuable upon exercise of a Warrant, the Company shall give written notice thereof to the
        Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment and the increase or decrease, if any, in the number of shares of Common Stock purchasable at such price upon the exercise of a Warrant, setting forth in
        reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence of any event specified in Sections 4.1, 4.2, 4.3 or 4.4, the Company shall give written notice of
        the occurrence of such event to each Registered Holder, at the last address set forth for such holder in the Warrant Register, of the record date or the effective date of the event. Failure to give such notice, or any defect therein, shall not
        affect the legality or validity of such event.

       

      4.6 No Fractional Shares. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall not issue fractional shares of Common Stock upon the exercise of Warrants. If, by reason
        of any adjustment made pursuant to this Section 4, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon such exercise, round down to the nearest
        whole number the number of shares of Common Stock to be issued to such holder.

       

      4.7 Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants issued after such adjustment may state the same Warrant Price and the
        same number of shares of Common Stock as is stated in the Warrants initially issued pursuant to this Agreement; provided, however, that the Company may at any time in its sole discretion make any change in the form of Warrant that
        the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

       

      4.8 Other Events. In case any event shall occur affecting the Company as to which none of the provisions of preceding subsections of this Section 4 are strictly applicable, but which would require an
        adjustment to the terms of the Warrants in order to (i) avoid an adverse impact on the Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case, the Company shall appoint a firm of independent public
        accountants, investment banking or other appraisal firm of recognized national standing, which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary to effectuate the intent and purpose of
        this Section 4 and, if they determine that an adjustment is necessary, the terms of such adjustment. The Company shall adjust the terms of the Warrants in a manner that is consistent with any adjustment recommended in such opinion.

       

      
        
          

      

      5.   Transfer and Exchange of Warrants.

       

      5.1 Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the Warrant Register, upon surrender of such Warrant for transfer, in the case
        of certificated Warrants, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants shall be issued and
        the old Warrant shall be cancelled by the Warrant Agent. In the case of certificated Warrants, the Warrants so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon request.

       

      5.2 Procedure for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request for exchange or transfer, and thereupon the Warrant Agent shall issue in exchange
        therefor one or more new Warrants as requested by the Registered Holder of the Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however, that except as otherwise provided herein or in any
        Book-Entry Warrant Certificate or Definitive Warrant Certificate, each Book-Entry Warrant Certificate and Definitive Warrant Certificate may be transferred only in whole and only to the Depositary, to another nominee of the Depositary, to a
        successor depository, or to a nominee of a successor depository; provided further, however, that in the event that a Warrant surrendered for transfer bears a restrictive legend (as in the case of the Private Placement
        Warrants and Forward Purchase Warrants), the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange thereof until the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made
        and indicating whether the new Warrants must also bear a restrictive legend.

       

      5.3 Fractional Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which shall result in the issuance of a warrant certificate or book-entry position for a
        fraction of a warrant.

       

      5.4 Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

       

      5.5 Warrant Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms of this Agreement, the Warrants required to be issued pursuant
        to the provisions of this Section 5, and the Company, whenever required by the Warrant Agent, shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

       

      5.6 Transfer of Warrants. Prior to the Detachment Date, the Public Warrants may be transferred or exchanged only together with the Unit in which such Warrant is included, and only for the purpose of
        effecting, or in conjunction with, a transfer or exchange of such Unit. Furthermore, each transfer of a Unit on the register relating to such Units shall operate also to transfer the Warrants included in such Unit. Notwithstanding the foregoing,
        the provisions of this Section 5.6 shall have no effect on any transfer of Warrants on and after the Detachment Date.

       

      6.   Redemption.

       

      6.1 Redemption. Subject to Section 6.4 hereof, not less than all of the outstanding Warrants may be redeemed, at the option of the Company, at any time while they are exercisable and prior to their
        expiration, at the office of the Warrant Agent, upon notice to the Registered Holders of the Warrants, as described in Section 6.2 below, at the price of $0.01 per Warrant (the “Redemption Price”), provided that the last sales price of the Common Stock reported has
        been at least $18.00 per share (subject to adjustment in compliance with Section 4 hereof), on each of twenty (20) trading days within the thirty (30) trading-day period ending on the third trading day prior to the date on which notice of
        the redemption is given and provided that there is an effective registration statement covering the shares of Common Stock issuable upon exercise of the Warrants, and a current prospectus relating thereto, available throughout the 30-day Redemption
        Period (as defined in Section 6.2 below) or the Company has elected to require the exercise of the Warrants on a “cashless basis” pursuant to subsection 3.3.1; provided, however, that if and when the Public Warrants
        become redeemable by the Company, the Company may not exercise such redemption right if the issuance of shares of Common Stock upon exercise of the Public Warrants is not exempt from registration or qualification under applicable state blue sky
        laws or the Company is unable to effect such registration or qualification.

       

      
        
          

      

      6.2 Date Fixed for, and Notice of, Redemption. In the event that the Company elects to redeem all of the Warrants, the Company shall fix a date for the redemption (the “Redemption Date”). Notice of redemption shall be mailed by first class mail, postage prepaid, by the Company not less than thirty (30) days prior to the
        Redemption Date (the “30-day Redemption Period”) to the Registered
        Holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration books. Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly given whether or not the Registered
        Holder received such notice.

       

      6.3 Exercise After Notice of Redemption. The Warrants may be exercised, for cash (or on a “cashless basis” in accordance with subsection 3.3.1(b) of this Agreement) at any time after notice of
        redemption shall have been given by the Company pursuant to Section 6.2 hereof and prior to the Redemption Date. In the event that the Company determines to require all holders of Warrants to exercise their Warrants on a “cashless basis”
        pursuant to subsection 3.3.1, the notice of redemption shall contain the information necessary to calculate the number of shares of Common Stock to be received upon exercise of the Warrants, including the “Fair Market Value” (as such term
        is defined in subsection 3.3.1(b) hereof) in such case. On and after the Redemption Date, the record holder of the Warrants shall have no further rights except to receive, upon surrender of the Warrants, the Redemption Price.

       

      6.4 Exclusion of Certain Warrants. The Company agrees that the redemption rights provided in this Section 6 shall not apply to the Private Placement Warrants, Forward Purchase Warrants or the Post-IPO
        Warrants (if such Post-IPO Warrants provide that they are non-redeemable by the Company) if at the time of the redemption such Private Placement Warrants, Forward Purchase Warrants or Post-IPO Warrants continue to be held by the Sponsor or any
        Permitted Transferees, as applicable. However, once such Private Placement Warrants, Forward Purchase Warrants or Post-IPO Warrants are transferred (other than to Permitted Transferees under Section 2.6), the Company may redeem the Private
        Placement Warrants, Forward Purchase Warrants or the Post-IPO Warrants, provided that the criteria for redemption are met, including the opportunity of the holder of such Private Placement Warrants, Forward Purchase Warrants or Post-IPO Warrants to
        exercise the Private Placement Warrants, Forward Purchase Warrants or the Post-IPO Warrants prior to redemption pursuant to Section 6.3. Private Placement Warrants, Forward Purchase Warrants or Post-IPO Warrants (if such Post-IPO Warrants provide
        that they are non-redeemable by the Company) that are transferred to persons other than Permitted Transferees shall upon such transfer cease to be Private Placement Warrants, Forward Purchase Warrants or Post-IPO Warrants and shall become Public
        Warrants under this Agreement.

       

      7.   Other Provisions Relating to Rights of Holders of Warrants.

       

      7.1 No Rights as Stockholder. A Warrant does not entitle the Registered Holder thereof to any of the rights of a stockholder of the Company, including, without limitation, the right to receive dividends, or
        other distributions, exercise any preemptive rights to vote or to consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other matter.

       

      7.2 Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent may on such terms as to indemnity or otherwise as they may in
        their discretion impose (which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated, or destroyed. Any such new Warrant shall
        constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

       

      7.3 Reservation of Common Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued shares of Common Stock that shall be sufficient to permit the exercise in
        full of all outstanding Warrants issued pursuant to this Agreement.

       

      7.4 Registration of Common Stock; Cashless Exercise at Company’s Option.

       

      
        
          

      

      7.4.1 Registration of the Common Stock. The Company agrees that as soon as practicable, but in no event later than fifteen (15) Business Days after the closing of its initial Business Combination, it shall
        use its commercially reasonable best efforts to file with the Commission a registration statement for the registration, under the Securities Act, of the shares of Common Stock issuable upon exercise of the Warrants. The Company shall use its
        commercially reasonable best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Warrants in accordance with the
        provisions of this Agreement. If any such registration statement has not been declared effective by the 60th Business Day following the closing of the Business Combination, holders of the Warrants shall have the right, during the period beginning
        on the 61st Business Day after the closing of the Business Combination and ending upon such registration statement being declared effective by the Commission, and during any other period when the Company shall fail to have maintained an effective
        registration statement covering the shares of Common Stock issuable upon exercise of the Warrants, to exercise such Warrants on a “cashless basis,” by exchanging the Warrants (in accordance with Section 3(a)(9) of the Securities Act (or any
        successor rule) or another exemption) for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the difference between the
        Warrant Price and the “Fair Market Value” (as defined below) by (y) the Fair Market Value. Solely for purposes of this subsection 7.4.1, “Fair Market Value” shall mean the volume
        weighted last reported average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the date that notice of exercise is received by the Warrant Agent from the holder of such Warrants or its
        securities broker or intermediary. The date that notice of cashless exercise is received by the Warrant Agent shall be conclusively determined by the Warrant Agent. In connection with the “cashless exercise” of a Public Warrant, the Company shall,
        upon request, provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities law experience) stating that (i) the exercise of the Warrants on a cashless basis in accordance with this subsection

          7.4.1 is not required to be registered under the Securities Act and (ii) the shares of Common Stock issued upon such exercise shall be freely tradable under United States federal securities laws by anyone who is not an affiliate (as such term
        is defined in Rule 144 under the Securities Act (or any successor rule)) of the Company and, accordingly, shall not be required to bear a restrictive legend. Except as provided in subsection 7.4.2, for the avoidance of any doubt, unless and
        until all of the Warrants have been exercised or have expired, the Company shall continue to be obligated to comply with its registration obligations under the first three sentences of this subsection 7.4.1.

       

      7.4.2 Cashless Exercise at Company’s Option. If the Common Stock is at the time of any exercise of a Warrant not listed on a national securities exchange such that it satisfies the definition of a “covered
        security” under Section 18(b)(1) of the Securities Act (or any successor rule), the Company may, at its option, (i) require holders of Public Warrants who exercise Public Warrants to exercise such Public Warrants on a “cashless basis” in accordance
        with Section 3(a)(9) of the Securities Act (or any successor rule) as described in subsection 7.4.1 and (ii) in the event the Company so elects, the Company shall not be required to file or maintain in effect a registration statement for
        the registration, under the Securities Act, of the Common Stock issuable upon exercise of the Warrants, notwithstanding anything in this Agreement to the contrary. If the Company does not elect at the time of exercise to require a holder of Public
        Warrants who exercises Public Warrants to exercise such Public Warrants on a “cashless basis,” it agrees to use its commercially reasonable best efforts to register or qualify for sale the Common Stock issuable upon exercise of the Public Warrant
        under the blue sky laws of the state of residence of the exercising Public Warrant holder to the extent an exemption is not available.

       

      8.   Concerning the Warrant Agent and Other Matters.

       

      8.1 Payment of Taxes. The Company shall from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant Agent in respect of the issuance or delivery of shares of
        Common Stock upon the exercise of the Warrants, but the Company shall not be obligated to pay any transfer taxes in respect of the Warrants or such shares of Common Stock.

       

      8.2 Resignation, Consolidation, or Merger of Warrant Agent.

       

      8.2.1 Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged from all further duties and liabilities hereunder after
        giving sixty (60) days’ notice in writing to the Company. If the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant Agent in place of the Warrant
        Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after it has been notified in writing of such resignation or incapacity by the Warrant Agent, then the holder of any Warrant may apply to the Supreme
        Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost. Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation organized and
        existing under the laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and State of New York, and authorized under such laws to exercise corporate trust powers and subject to supervision
        or examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as if
        originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument
        transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all
        instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties, and obligations.

       

      
        
          

      

      8.2.2 Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the predecessor Warrant Agent and the Transfer Agent for the
        Common Stock not later than the effective date of any such appointment.

       

      8.2.3 Merger or Consolidation of Warrant Agent. Any corporation into which the Warrant Agent may be merged or with which it may be consolidated or any corporation resulting from any merger or consolidation
        to which the Warrant Agent shall be a party shall be the successor Warrant Agent under this Agreement without any further act.

       

      8.3 Fees and Expenses of Warrant Agent.

       

      8.3.1 Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder and shall, pursuant to its obligations under this Agreement, reimburse
        the Warrant Agent upon demand for all reasonable and documented third party expenditures that the Warrant Agent may reasonably incur in the execution of its duties hereunder.

       

      8.3.2 Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and delivered all such further and other acts, instruments, and
        assurances as may reasonably be required by the Warrant Agent for the carrying out or performing of the provisions of this Agreement.

       

      8.4 Liability of Warrant Agent.

       

      8.4.1 Reliance on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it necessary or desirable that any fact or matter be proved or established by
        the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by a statement signed by the
        Chief Executive Officer, Chief Financial Officer, President, Executive Vice President, Vice President, Secretary or Chairman of the Board of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any
        action taken or suffered in good faith by it pursuant to the provisions of this Agreement.

       

      8.4.2 Indemnity. The Warrant Agent shall be liable hereunder only for its own fraud, gross negligence, willful misconduct, bad faith or breach of this Agreement. The Company agrees to indemnify the Warrant
        Agent and save it harmless against any and all liabilities, including judgments, costs and reasonable counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Agreement, except for any amounts arising out of, in
        connection with or resulting from the Warrant Agent’s fraud, gross negligence, willful misconduct, bad faith or breach of this Agreement.

       

      8.4.3 Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or execution of any Warrant (except its countersignature
        thereof). The Warrant Agent shall not be responsible for any breach by the Company of any covenant or condition contained in this Agreement or in any Warrant. The Warrant Agent shall not be responsible to make any adjustments required under the
        provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment or the ascertaining of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make
        any representation or warranty as to the authorization or reservation of any shares of Common Stock to be issued pursuant to this Agreement or any Warrant or as to whether any shares of Common Stock shall, when issued, be valid and fully paid and
        non-assessable.

       

      8.5 Acceptance of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms and conditions herein set forth and among other things, shall
        account promptly to the Company with respect to Warrants exercised and concurrently account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of shares of Common Stock through the exercise of the Warrants.

       

      
        
          

      

      

      

      8.6 Waiver. The Warrant Agent has no right of set-off or any other right, title, interest or claim of any kind (“Claim”) in, or to any distribution
        of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date hereof, by and between the Company and the Warrant Agent as trustee thereunder) and hereby agrees not to seek recourse, reimbursement,
        payment or satisfaction for any Claim against the Trust Account for any reason whatsoever. The Warrant Agent hereby irrevocably waives any and all Claims against the Trust Account, including any monies therein or any distribution therefrom, and any
        and all rights to seek access to the Trust Account.

       

      9.   Miscellaneous Provisions.

       

      9.1 Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the benefit of their respective successors and assigns.

       

      9.2 Notices. Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant to or on the Company shall be sufficiently given when so
        delivered if by hand or overnight delivery, one business day after delivery to an overnight courier servicer, or if sent by certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, in each case
        addressed (until another address is filed in writing by the Company with the Warrant Agent), as follows:

       

      CF Acquisition Corp. IV

       

      110 East 59th Street

       

      New York, NY 10022

       

      Attention: Chief Executive Officer

       

      Any notice, statement or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently given when so delivered if by hand or overnight delivery, one
        business day after delivery to an overnight courier servicer, or if sent by certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, in each case addressed (until another address is filed in
        writing by the Warrant Agent with the Company), as follows:

       

      Continental Stock Transfer & Trust Company

       

      1 State Street, 30th Floor

       

      New York, NY 10004

       

      Attention: Compliance Department

       

      9.3 Applicable Law and Exclusive Forum. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all respects by the laws of the State of
        New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. Each party hereby agrees that any action, proceeding or claim against it arising out of or relating
        in any way to this Agreement shall be brought and enforced in the courts of the State of New York in the Borough of Manhattan or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction,
        which jurisdiction shall be exclusive forum for any such action, proceeding or claim. Each party hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Notwithstanding the foregoing, the
        provisions of this paragraph will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum.

       

      Any person or entity purchasing or otherwise acquiring any interest in the Warrants shall be deemed to have notice of and to have consented to the forum provisions in this Section 9.3.
        If any action, the subject matter of which is within the scope the forum provisions above, is filed in a court other than a court located within the State of New York in the Borough of Manhattan or the United States District Court for the Southern
        District of New York (a “foreign action”) in the name of any warrant holder, such warrant holder shall be deemed to have consented to: (x) the personal jurisdiction of the state and
        federal courts located within the State of New York in the Borough of Manhattan or the United States District Court for the Southern District of New York in connection with any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having service of process made upon such warrant holder in any such enforcement action by service upon such warrant holder’s counsel in the foreign action as
        agent for such warrant holder.

       

      9.4 Persons Having Rights under this Agreement. Nothing in this Agreement shall be construed to confer upon, or give to, any person or corporation other than the parties hereto and the Registered Holders of
        the Warrants any right, remedy, or claim under or by reason of this Agreement or of any covenant, condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Agreement
        shall be for the sole and exclusive benefit of the parties hereto and their successors and assigns and of the Registered Holders of the Warrants.

       

      
        
          

      

      9.5 Examination of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the Warrant Agent in the Borough of Manhattan, City and State of New York, for
        inspection by the Registered Holder of any Warrant. The Warrant Agent may require any such holder to submit such holder’s Warrant for inspection by the Warrant Agent.

       

      9.6 No Waiver of Rights, Powers and Remedies. No failure or delay by a party hereto in exercising any right, power or remedy under this Agreement, and no course of dealing between the parties hereto, shall
        operate as a waiver of any such right, power or remedy of such party. No single or partial exercise of any right, power or remedy under this Agreement by a party hereto, nor any abandonment or discontinuance of steps to enforce any such right,
        power or remedy, shall preclude such party from any other or further exercise thereof or the exercise of any other right, power or remedy hereunder. The election of any remedy by a party hereto shall not constitute a waiver of the right of such
        party to pursue other available remedies. No notice to or demand on a party not expressly required under this Agreement shall entitle the party receiving such notice or demand to any other or further notice or demand in similar or other
        circumstances or constitute a waiver of the rights of the party giving such notice or demand to any other or further action in any circumstances without such notice or demand.

       

      9.7 Counterparts. This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such
        counterparts shall together constitute but one and the same instrument. In the event that any signature is delivered by facsimile transmission or any other form of electronic delivery, such signature shall create a valid and binding obligation of
        the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.

       

      9.8 Effect of Headings. The section headings herein are for convenience only and are not part of this Agreement and shall not affect the interpretation thereof.

       

      9.9 Amendments. This Agreement may be amended by the parties hereto without the consent of any Registered Holder (i) for the purpose of curing any ambiguity, or curing, correcting or supplementing any
        defective provision contained herein or adding or changing any other provisions with respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect
        the interest of the Registered Holders, and (ii) to provide for the delivery of Alternative Issuance pursuant to Section 4.4. All other modifications or amendments, including any amendment to increase the Warrant Price or shorten the Exercise
        Period, shall require the vote or written consent of the Registered Holders of a majority of the then outstanding Public Warrants. Any amendment solely to the Private Placement Warrants or Forward Purchase Warrants shall require the vote or written
        consent of a majority of the holders of the then outstanding Private Placement Warrants or Forward Purchase Warrants, respectively. Notwithstanding the foregoing, the Company may lower the Warrant Price or extend the duration of the Exercise Period
        pursuant to Sections 3.1 and 3.2, respectively, without the consent of the Registered Holders.

       

      9.10 Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Agreement or of any
        other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or
        unenforceable provision as may be possible and be valid and enforceable.

       

      [Signature Page Follows]

       

      
        
          

      

      IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.

      

      

      	 	
              CF ACQUISITION CORP. IV

            
	 	 	 
	 	By:	/s/Paul Pion
	 	
              Name:

            	
              Paul Pion

            
	 	
              Title:

            	
              Chief Financial Officer

            

      

      

      	 	
              CONTINENTAL STOCK TRANSFER

              & TRUST COMPANY, as Warrant Agent

            
	 	 	 
	 	
              By:

            	

            
	 	
              Name:

            	
              Steven Vacante

            
	 	
              Title:

            	
              Vice President

            

      

      

      [Signature Page to Warrant Agreement - CF Acquisition Corp. IV]

       

      
        
          

      

      EXHIBIT A

       

      [Form of Warrant Certificate]

       

      [FACE]

       

      Number

       

      Warrants

       

      THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO

       

      THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR

       

      IN THE WARRANT AGREEMENT DESCRIBED BELOW

       

      CF ACQUISITION CORP. IV

       

      Incorporated Under the Laws of the State of Delaware

       

      CUSIP 12520T 110

       

      Warrant Certificate

       

      This Warrant Certificate certifies that , or registered assigns, is the registered holder of warrant(s) evidenced hereby (the “Warrants” and each, a “Warrant”) to purchase shares of Class A common stock, $0.0001 par value per share (“Common Stock”), of CF Acquisition Corp. IV, a Delaware corporation (the “Company”). Each Warrant entitles the
        holder, upon exercise during the period set forth in the Warrant Agreement referred to below, to receive from the Company that number of fully paid and non-assessable shares of Common Stock as set forth below, at the exercise price (the “Exercise Price”) as determined pursuant to the Warrant Agreement, payable in lawful money (or through “cashless exercise” as provided for in the Warrant Agreement) of the United States of America upon surrender of this Warrant Certificate and payment of
        the Exercise Price at the office or agency of the Warrant Agent referred to below, subject to the conditions set forth herein and in the Warrant Agreement. Defined terms used in this Warrant Certificate but not defined herein shall have the
        meanings given to them in the Warrant Agreement.

       

      Each whole Warrant is initially exercisable for one fully paid and non-assessable share of Common Stock. No fractional shares will be issued upon exercise of any Warrant. If, upon the exercise of Warrants, a holder
        would be entitled to receive a fractional interest in a share of Common Stock, the Company will, upon exercise, round down to the nearest whole number the number of shares of Common Stock to be issued to the Warrant holder. The number of shares of
        Common Stock issuable upon exercise of the Warrants is subject to adjustment upon the occurrence of certain events set forth in the Warrant Agreement.

       

      The initial Exercise Price per share of Common Stock for any Warrant is equal to $11.50 per share. The Exercise Price is subject to adjustment upon the occurrence of certain events set forth in the Warrant Agreement.

       

      Subject to the conditions set forth in the Warrant Agreement, the Warrants may be exercised only during the Exercise Period and to the extent not exercised by the end of such Exercise Period, such Warrants shall become
        void. The Warrants may be redeemed, subject to certain conditions, as set forth in the Warrant Agreement.

       

      Reference is hereby made to the further provisions of this Warrant Certificate set forth on the reverse hereof and such further provisions shall for all purposes have the same effect as though fully set forth at this
        place.

       

      This Warrant Certificate shall not be valid unless countersigned by the Warrant Agent, as such term is used in the Warrant Agreement.

       

      This Warrant Certificate shall be governed by and construed in accordance with the internal laws of the State of New York, without regard to conflicts of laws principles thereof.

       

      
        
          

      

      	 	
              CF ACQUISITION CORP. IV

            
	 	 	 
	 	
              By:

            	

            
	 	
              Name:

            	 
	 	
              Title:

            	 

      

      

      	 	
              CONTINENTAL STOCK TRANSFER

              & TRUST COMPANY, as Warrant Agent

            
	 	 	 
	 	
              By:

            	

            
	 	
              Name:

            	 
	 	
              Title:

            	 

      

      

      
        
          

      

       [Form of Warrant Certificate]

       

      [Reverse]

       

      The Warrants evidenced by this Warrant Certificate are part of a duly authorized issue of Warrants entitling the holder on exercise to receive shares of Common Stock and are issued or to be issued pursuant to a Warrant
        Agreement dated as of , 2020 (the “Warrant Agreement”), duly executed and delivered by the Company to Continental Stock Transfer
        & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”), which Warrant Agreement is hereby
        incorporated by reference in and made a part of this instrument and is hereby referred to for a description of the rights, limitation of rights, obligations, duties and immunities thereunder of the Warrant Agent, the Company and the holders (the
        words “holders” or “holder” meaning the Registered Holders or Registered Holder) of the Warrants. A copy of the Warrant
        Agreement may be obtained by the holder hereof upon written request to the Company. Defined terms used in this Warrant Certificate but not defined herein shall have the meanings given to them in the Warrant Agreement.

       

      Warrants may be exercised at any time during the Exercise Period set forth in the Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate may exercise them by surrendering this Warrant
        Certificate, with the form of election to purchase set forth hereon properly completed and executed, together with payment of the Exercise Price as specified in the Warrant Agreement (or through “cashless exercise” as provided for in the Warrant
        Agreement) at the principal corporate trust office of the Warrant Agent. In the event that upon any exercise of Warrants evidenced hereby the number of Warrants exercised shall be less than the total number of Warrants evidenced hereby, there shall
        be issued to the holder hereof or his, her or its assignee, a new Warrant Certificate evidencing the number of Warrants not exercised.

       

      Notwithstanding anything else in this Warrant Certificate or the Warrant Agreement, no Warrant may be exercised unless at the time of exercise (i) a registration statement covering the shares of Common Stock to be
        issued upon exercise is effective under the Securities Act and (ii) a prospectus thereunder relating to the shares of Common Stock is current, except through “cashless exercise” as provided for in the Warrant Agreement.

       

      The Warrant Agreement provides that upon the occurrence of certain events the number of shares of Common Stock issuable upon exercise of the Warrants set forth on the face hereof may, subject to certain conditions, be
        adjusted. If, upon exercise of a Warrant, the holder thereof would be entitled to receive a fractional interest in a share of Common Stock, the Company shall, upon exercise, round down to the nearest whole number of shares of Common Stock to be
        issued to the holder of the Warrant.

       

      Warrant Certificates, when surrendered at the principal corporate trust office of the Warrant Agent by the Registered Holder thereof in person or by legal representative or attorney duly authorized in writing, may be
        exchanged, in the manner and subject to the limitations provided in the Warrant Agreement, but without payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing in the aggregate a like number of
        Warrants.

       

      Upon due presentation for registration of transfer of this Warrant Certificate at the office of the Warrant Agent, a new Warrant Certificate or Warrant Certificates of like tenor and evidencing in the aggregate a like
        number of Warrants shall be issued to the transferee(s) in exchange for this Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge except for any tax or other governmental charge imposed in connection
        therewith.

       

      The Company and the Warrant Agent may deem and treat the Registered Holder(s) hereof as the absolute owner(s) of this Warrant Certificate (notwithstanding any notation of ownership or other writing hereon made by
        anyone), for the purpose of any exercise hereof, of any distribution to the holder(s) hereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. Neither the Warrants nor this
        Warrant Certificate entitles any holder hereof to any rights of a stockholder of the Company.

       

      
        
          

      

      Election to Purchase

       

      (To Be Executed Upon Exercise of Warrant)

       

      The undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, to receive shares of Common Stock and herewith tenders payment for such shares of Common Stock to the order of
        CF Acquisition Corp. IV (the “Company”) in the amount of $ in accordance with the terms hereof. The undersigned requests that a certificate for such shares of Common Stock be registered in the name of , whose
        address is and that such shares of Common Stock be delivered to whose address is . If said number of shares of Common Stock is less than all of the shares of Common Stock purchasable hereunder, the undersigned requests that a new Warrant
        Certificate representing the remaining balance of such shares of Common Stock be registered in the name of , whose address is and that such Warrant Certificate be delivered to , whose address is .

       

      In the event that the Warrant has been called for redemption by the Company pursuant to Section 6 of the Warrant Agreement and the Company has required cashless exercise pursuant to Section 6.3 of the
        Warrant Agreement, the number of shares of Common Stock that this Warrant is exercisable for shall be determined in accordance with subsection 3.3.1(b) and Section 6.3 of the Warrant Agreement.

       

      In the event that the Warrant is a Private Placement Warrant or Forward Purchase Warrant that is to be exercised on a “cashless” basis pursuant to subsection 3.3.1(c) of the Warrant Agreement, the number of
        shares of Common Stock that this Warrant is exercisable for shall be determined in accordance with subsection 3.3.1(c) of the Warrant Agreement.

       

      In the event that the Warrant is to be exercised on a “cashless” basis pursuant to Section 7.4 of the Warrant Agreement, the number of shares of Common Stock that this Warrant is exercisable for shall be
        determined in accordance with Section 7.4 of the Warrant Agreement.

       

      In the event that the Warrant may be exercised, to the extent allowed by the Warrant Agreement, through cashless exercise (i) the number of shares of Common Stock that this Warrant is exercisable for would be
        determined in accordance with the relevant section of the Warrant Agreement which allows for such cashless exercise and (ii) the holder hereof shall complete the following: The undersigned hereby irrevocably elects to exercise the right,
        represented by this Warrant Certificate, through the cashless exercise provisions of the Warrant Agreement, to receive shares of Common Stock. If said number of shares is less than all of the shares of Common Stock purchasable hereunder (after
        giving effect to the cashless exercise), the undersigned requests that a new Warrant Certificate representing the remaining balance of such shares of Common Stock be registered in the name of , whose address is and that such Warrant Certificate be
        delivered to , whose address is .

       

      [Signature Page Follows]

       

      
        
          

      

      

      	
              Date: , 20

            	 	 	 
	 	 	
              (Signature)

            	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	
              (Address)

            	 
	 	 	 	 
	 	 	 	 
	 	 	
              (Tax Identification Number)

            	 
	 	 	 	 
	
              Signature Guaranteed:

            	 	 	 
	 	 	 	 

      

      

      THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE
        17Ad-15 (OR ANY SUCCESSOR RULE)).

       

      
        
          

      

      EXHIBIT B

       

      LEGEND

       

      “THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE
        SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, SUBJECT TO ANY ADDITIONAL LIMITATIONS ON TRANSFER DESCRIBED IN THE LETTER AGREEMENT BY AND AMONG CF
        ACQUISITION CORP. IV (THE “COMPANY”), CFAC HOLDINGS IV, LLC AND THE OTHER PARTIES THERETO, THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD OR TRANSFERRED PRIOR TO THE DATE THAT IS THIRTY (30) DAYS AFTER THE DATE UPON WHICH THE
        COMPANY COMPLETES ITS INITIAL BUSINESS COMBINATION (AS DEFINED IN SECTION 3 OF THE WARRANT AGREEMENT REFERRED TO HEREIN) EXCEPT TO A PERMITTED TRANSFEREE (AS DEFINED IN SECTION 2 OF THE WARRANT AGREEMENT) WHO AGREES IN WRITING WITH THE COMPANY TO
        BE SUBJECT TO SUCH TRANSFER PROVISIONS.

       

      SECURITIES EVIDENCED BY THIS CERTIFICATE AND SHARES OF CLASS A COMMON STOCK OF THE COMPANY ISSUED UPON EXERCISE OF SUCH SECURITIES SHALL BE ENTITLED TO REGISTRATION RIGHTS UNDER A REGISTRATION RIGHTS AGREEMENT TO BE EXECUTED BY THE COMPANY.”

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]